Psychotropic Drugs

"Psychotropic Drugs" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents).

Descriptor ID	D011619
MeSH Number(s)	D27.505.954.427.700
Concept/Terms	Psychotropic Drugs Psychotropic Drugs Drugs, Psychotropic Psychopharmaceuticals Psychoactive Agents Agents, Psychoactive Psychoactive Drugs Drugs, Psychoactive

Below are MeSH descriptors whose meaning is more general than "Psychotropic Drugs".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Central Nervous System Agents [D27.505.954.427]
Psychotropic Drugs [D27.505.954.427.700]

Below are MeSH descriptors whose meaning is related to "Psychotropic Drugs".

Below are MeSH descriptors whose meaning is more specific than "Psychotropic Drugs".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Psychotropic Drugs" by people in this website by year, and whether "Psychotropic Drugs" was a major or minor topic of these publications.

Bar chart showing 102 publications over 27 distinct years, with a maximum of 10 publications in 2010

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1991	2	0	2
1992	1	1	2
1994	1	0	1
1997	2	0	2
1998	3	1	4
1999	0	4	4
2000	1	3	4
2001	1	1	2
2002	2	3	5
2003	3	1	4
2004	1	0	1
2005	0	2	2
2006	0	1	1
2007	3	5	8
2008	5	0	5
2009	2	2	4
2010	4	6	10
2011	3	2	5
2012	4	2	6
2013	3	0	3
2014	1	2	3
2015	6	0	6
2016	2	0	2
2017	3	1	4
2018	4	1	5
2019	6	0	6
2021	0	1	1

Below are the most recent publications written about "Psychotropic Drugs" by people in Profiles.

Jazzar U, Bergerot CD, Shan Y, Wallis CJD, Freedland SJ, Kamat AM, Tyler DS, Baillargeon J, Kuo YF, Klaassen Z, Williams SB. Use of psychotropic drugs among older patients with bladder cancer in the United States. Psychooncology. 2021 06; 30(6):832-843.

View in: PubMed
Fletcher TL, Hundt NE, Kunik ME, Singh H, Stanley MA. Accuracy of Anxiety Disorder Not Otherwise Specified Diagnosis in Older Veterans. J Psychiatr Pract. 2019 09; 25(5):358-364.

View in: PubMed
Bodkin JA, Coleman MJ, Godfrey LJ, Carvalho CMB, Morgan CJ, Suckow RF, Anderson T, Öngür D, Kaufman MJ, Lewandowski KE, Siegel AJ, Waldstreicher E, Grochowski CM, Javitt DC, Rujescu D, Hebbring S, Weinshilboum R, Rodriguez SB, Kirchhoff C, Visscher T, Vuckovic A, Fialkowski A, McCarthy S, Malhotra D, Sebat J, Goff DC, Hudson JI, Lupski JR, Coyle JT, Rudolph U, Levy DL. Targeted Treatment of Individuals With Psychosis Carrying a Copy Number Variant Containing a Genomic Triplication of the Glycine Decarboxylase Gene. Biol Psychiatry. 2019 10 01; 86(7):523-535.

View in: PubMed
Upadhyay N, Patel A, Chan W, Aparasu RR, Ochoa-Perez M, Sherer JT, Sanyal S, Chen H. Reversibility of psychotropic medication induced weight gain among children and adolescents with bipolar disorders. Psychiatry Res. 2019 06; 276:151-159.

View in: PubMed
Mire SS, McQuillin S, Racine M, Goin-Kochel RP. Using latent class analysis to identify treatment-use subgroups among parents of children with autism spectrum disorder. Autism Res. 2019 05; 12(5):843-854.

View in: PubMed
Azhar A, Haider A, Ali Naqvi SM, Wong AN, Dibaj SS, Liu DD, Williams JL, Bruera E. Frequency of Concomitant Use of Opioids and Psychoactive Medications Among Cancer Patients Referred to Outpatient Palliative Care. J Pain Symptom Manage. 2019 06; 57(6):e7-e10.

View in: PubMed
Medhekar R, Fujimoto K, Aparasu RR, Bhatara VS, Johnson ML, Alonzo JP, Schwarzwald HL, Chen H. Physician Care Coordination and the Use of Psychotropic Polypharmacy in the Management of Pediatric Mental Disorders. J Manag Care Spec Pharm. 2019 Jan; 25(1):29-38.

View in: PubMed
Hu Q, Wang C, Liu F, He J, Wang F, Wang W, You P. High serum levels of FGF21 are decreased in bipolar mania patients during psychotropic medication treatment and are associated with increased metabolism disturbance. Psychiatry Res. 2019 02; 272:643-648.

View in: PubMed
Medhekar R, Aparasu R, Bhatara V, Johnson M, Alonzo J, Schwarzwald H, Chen H. Risk factors of psychotropic polypharmacy in the treatment of children and adolescents with psychiatric disorders. Res Social Adm Pharm. 2019 04; 15(4):395-403.

View in: PubMed
Yucel A, Essien EJ, Sanyal S, Mgbere O, Aparasu RR, Bhatara VS, Alonzo JP, Chen H. Racial/ethnic differences in the treatment of adolescent major depressive disorders (MDD) across healthcare providers participating in the medicaid program. J Affect Disord. 2018 08 01; 235:155-161.

View in: PubMed

People

Explore

Similar Concepts

Top Journals